Correlation Between Seres Therapeutics and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Seres Therapeutics and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Reviva Pharmaceuticals.
Diversification Opportunities for Seres Therapeutics and Reviva Pharmaceuticals
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Seres and Reviva is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Reviva Pharmaceuticals
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 0.92 times more return on investment than Reviva Pharmaceuticals. However, Seres Therapeutics is 1.09 times less risky than Reviva Pharmaceuticals. It trades about 0.16 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about 0.0 per unit of risk. If you would invest 70.00 in Seres Therapeutics on August 29, 2024 and sell it today you would earn a total of 18.00 from holding Seres Therapeutics or generate 25.71% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Seres Therapeutics vs. Reviva Pharmaceuticals Holding
Performance |
Timeline |
Seres Therapeutics |
Reviva Pharmaceuticals |
Seres Therapeutics and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Seres Therapeutics and Reviva Pharmaceuticals
The main advantage of trading using opposite Seres Therapeutics and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Reviva Pharmaceuticals vs. Bright Minds Biosciences | Reviva Pharmaceuticals vs. HP Inc | Reviva Pharmaceuticals vs. Intel | Reviva Pharmaceuticals vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |